Food and Drug Administration (FDA) for the treatment, prevention, or cure of any disease or medical condition
For research purposes only 122 Treetops Victoria Gardens, Colchester, CO4 9YE [email protected] +447449201766 Newsletter Join our mailing list for research updates, exclusive offers, and the latest news
Anecdotal reports and statements from healthcare professionals suggest that a significant number of peopleparticularly young adults and social media influencersare using these drugs without medical necessity
Using sterile water (which has no preservative) is an option only if you plan to use the entire vial in a single session, which is rarely practical
Don't expect a dramatic transformation at week three
Case 1 Male patient died while receiving semaglutide report invalidated because call-center contractors claimed patient identifier was missing (FDA found it in source documents) Case 2 Consumer taking liraglutide suffered a disabling stroke report cancelled because the consumer said it was unrelated to the drug Case 3 Patient taking semaglutide became depressed and committed suicide no follow-up attempts documented, still not submitted to FDA as of March 2026 Case 4 Consumer reported suicidal ideation on semaglutide in December 2024 not reviewed until February 2025, only after FDA inspectors flagged it Case 5 FDA found Novo Nordisk's written procedures allowed adverse events to be rejected based on causality assessments contradicting federal reporting requirements A Second Front: Vision Loss Claims Beyond the GI injury cases, a second GLP-1 MDL was created in December 2025 for vision loss claims
